Proactive IP Risk Management for Innovators - Introducing the Quarterly mRNA Therapeutics Patent Monitoring Service
19 Sep 2023
VaccinemRNAsiRNAPatent Infringement
DUBLIN, Sept. 19, 2023 /PRNewswire/ -- The "Therapeutic mRNA Patent Monitor" newsletter has been added to
ResearchAndMarkets.com's offering.
The global mRNA therapeutics landscape is experiencing a transformative era, with mRNA-based vaccines leading the way in responding to the COVID-19 pandemic.
The remarkable success of these vaccines has not only revolutionized immunization but also brought to the forefront the immense potential of mRNA technology in treating a wide range of diseases and conditions. As this field rapidly evolves, understanding the intellectual property (IP) landscape is crucial for businesses and researchers to identify opportunities, navigate challenges, and stay competitive.
Introducing the mRNA Therapeutics Patent Monitoring Service:
Quarterly Updates: Stay ahead of the curve with quarterly-updated Excel files, comprehensive analysis reports, and direct access to the publisher's expert analysts.
IP Insights: Gain deep insights into the latest IP trends, key players, and emerging technologies in the mRNA therapeutics sector.
Competitor Analysis: Keep a watchful eye on your competitors' IP activities, R&D strategies, and technology developments to inform your own strategic decisions.
Risk Mitigation: Proactively manage IP risks by monitoring new patent applications, preventing harmful IP rights registrations, and swiftly responding to infringements.
Service Features:
Quarterly Updates: Access an Excel database containing valuable information on new patent applications, recently granted patents, expired/abandoned patents, IP transfers (re-assignments, licensing), and patent litigation/opposition.
Thematic Segmentation: Patents are categorized by technology segments, application areas, and therapeutic domains, including mRNA design, delivery methods, manufacturing processes, mRNA-based vaccines, mRNA-based therapeutics, infectious diseases, oncological disorders, and various other diseases.
Online Database Access: Hyperlinks to an updated online database provide legal status and document access for further research.
Direct Analyst Interaction: Benefit from direct interactions with our expert analysts, including on-demand Q&A sessions and discussions tailored to your specific needs.
Key Companies in the mRNA Therapeutics Field:
The mRNA Therapeutics Patent Monitoring Service provides insights into the IP strategies of key players in the field, including:
Abnova
Arcturus
Celanese
Daiichi Sankyo
Dompe
Gnereation Bio
Leon
Magle Chemoswed
Moderna
nference
Replicate
UreVac
The mRNA Therapeutics Patent Monitoring Service offers a comprehensive and strategic approach to navigating the evolving mRNA therapeutics landscape. It empowers businesses, researchers, and innovators to make informed decisions, identify emerging research areas, and understand competitors' IP strategies in this dynamic field.
For more information about this newsletter visit https://www.researchandmarkets.com/r/na9qep
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.